atomoxetine hydrochloride has been researched along with Cardiac Arrest, Sudden in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berg, A; BrĂ¥tane, E; Brudvik, C; Hirth, A; Odland, HH; Rosland, B | 1 |
Awudu, GA; Besag, FM | 1 |
Vitiello, B | 1 |
3 review(s) available for atomoxetine hydrochloride and Cardiac Arrest, Sudden
Article | Year |
---|---|
[Cardiovascular risk assessment for the use of ADHD drugs in children].
Topics: Adolescent; Adrenergic Uptake Inhibitors; Algorithms; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Death, Sudden, Cardiac; Electrocardiography; Heart Diseases; Humans; Medical History Taking; Practice Guidelines as Topic; Propylamines; Risk Assessment; Risk Factors | 2014 |
Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update.
Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Death, Sudden, Cardiac; Heart Rate; Humans; Methylphenidate; Propylamines | 2014 |
Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Appetite; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Height; Central Nervous System Stimulants; Child; Child, Preschool; Controlled Clinical Trials as Topic; Death, Sudden, Cardiac; Electrocardiography; Heart Rate; Humans; Long-Term Care; Methylphenidate; Propylamines; Risk Factors | 2008 |
1 other study(ies) available for atomoxetine hydrochloride and Cardiac Arrest, Sudden
Article | Year |
---|---|
ADHD update: new data on the risks of medication.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Death, Sudden, Cardiac; Drug Overdose; Growth Disorders; Humans; Methylphenidate; Propylamines | 2006 |